Our People
University of Montreal, Montreal, Quebec, Canada
Chief Scientific Officer, SciNeuro Pharmaceuticals
Editor-in-Chief, Molecular Neurodegeneration
Departments of Neuroscience and Ophthalmology
NYU Langone Health, New York
New York Neural Stem Cell Institute
University at Albany, New York
Harvard Medical School, Boston Children’s Hospital, Boston, MA
University of Colorado School of Medicine, Denver, CO
Byers Eye Institute, Stanford University School of Medicine, Palo Alto, CA
Harvard Medical School, Boston Children’s Hospital, Boston, MA
Columbia University College of Physicians and Surgeons, New York, NY
University of Montreal, Montreal, Quebec, Canada
Devers Eye Institute, Legacy Research Institute, Portland, OR
Massachusetts Eye and Ear, Harvard Medical School, Boston, MA
University of Alabama at Birmingham, Callahan Eye Foundation Hospital, Birmingham, AL
Department of Molecular Biosciences, University of Texas at Austin
Devers Eye Institute, Legacy Health, Portland, OR
Duke University, Durham, NC
Stark Neurosciences Research Institute, Indiana University School of Medicine
Indianapolis, IN
University of Pennsylvania, Scheie Eye Institute, Philadelphia, PA
Professor of Ophthalmology, Kenneth L. Roper, MD Endowed Chair; Vice Chair for Research Innovation, Vickie and Jack Farber Vision Research Center; Co-Director, Glaucoma Service, Wills Eye Hospital
Duke University, Durham, NC
University of Regensburg, Regensburg, Germany
Massachusetts Eye and Ear, Harvard Medical School, Boston, MA
University of Utah, Salt Lake City, UT
President and Founder, Afex International, Inc.
Houston, Texas
GRF Board Emeritus 2003-2009
Executive Director, The Edward J. Daly Foundation
San Francisco, California
GRF Board Emeritus 2001-2010
San Francisco, California
GRF Board Emeritus 1989-1995
Philanthropist and Entrepreneur
San Jose, California
Singer-Guitarist, Co-founder of The Byrds
Windemere, Florida
Lafayette, California
Board Emeritus 1991-1999
Former Chairman and CEO of Allergan, Inc.
Irvine, California
Alcon, Inc. (retired)
Cle Elum, WA
The Gleams Newsletter includes interviews, personal stories, and current information about glaucoma, new treatments, updates on research findings, and more. You can subscribe to the printed version of Gleams or the electronic version — both are free.
The Gleams Newsletter includes interviews, personal stories, and current information about glaucoma, new treatments, updates on research findings, and more. You can subscribe to the printed version of Gleams or the electronic version — both are free.
FOR EYECARE PROFESSIONALS
FOR EYECARE PROFESSIONALS
Glaucoma Research Foundation • 251 Post Street, Suite 600 • San Francisco, CA 94108 • 415-986-3162
Send us an email
We are a 501c3 tax-exempt national nonprofit. Our tax ID number is 94-2495035. Our EIN number is 94-2495035.
Copyright 2023 all rights reserved.
Print Subscription
We will mail Gleams anywhere in the United States and Canada, but we do not mail internationally. Please sign up for the email edition if you live outside of the US or Canada.
You can unsubscribe at any time. GRF will not share your personal information with any other organizations. Please see our Privacy Policy for further information.
E-mail Subscription
You can unsubscribe at any time. GRF will not share your personal information with any other organizations. Please see our Privacy Policy for further information.